Apparently "low" serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes

---

Onat A., KOROGLU B., Can G., KARAGÖZ A., Yuksel M., Aydin M.

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.14, sa.1, ss.26-33, 2014 (SCI-Expanded, Scopus, TRDizin)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 14 Sayı: 1
• Basım Tarihi: 2014
• Doi Numarası: 10.5152/akd.2013.5009
• Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.26-33
• Anahtar Kelimeler: asymmetric dimethylarginine, diabetes type-2, glucose, oxidative stress, sex difference, regression analysis, CORONARY-ARTERY-DISEASE, ADVERSE CARDIOVASCULAR EVENTS, OXIDE SYNTHASE INHIBITOR, ENDOTHELIAL FUNCTION, METABOLIC SYNDROME, L-ARGININE, RHEUMATOID-ARTHRITIS, RENAL-DISEASE, RISK-FACTORS, TURKISH MEN
• Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
• İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Objective: We investigated the association of serum asymmetric dimethylarginine (ADMA) with metabolic syndrome (MetS), type-2 diabetes and coronary heart disease (CHD) in the general population.